Feb. 13, 2024
by Dana Sokolova
Biopharma insight
The biotech and pharmaceutical industries are entering 2024 amid a wave of innovation and technological advancement. The biopharma field is …
Feb. 7, 2024
by Roman Kasianov
News
Exscientia plc, a UK-based AI-driven precision medicine company, has initiated a clinical study, EXCYTE-2, focusing on acute myeloid leukaemia (AML) patients. …
Feb. 6, 2024
by Andrii Buvailo, PhD
Interview
As we stand at the crossroads of artificial intelligence (AI) and biotech, what future awaits protein design, and how are …
Feb. 2, 2024
by News Team
News
Aqemia, a Paris-based biotech startup, raised an additional €30 million in a Series A funding extension, totaling €60 million in …
Jan. 26, 2024
by Natalia Honchar
Biopharma insight
When we hear “AI in drug discovery”, there is a high chance our imagination would draw a small molecule discovery …
Jan. 26, 2024
by Andrii Buvailo, PhD
Biopharma insight
The year 2024 has ushered in a new wave of excitement in the biotech industry, with several promising companies making …
Jan. 23, 2024
by Andrii Buvailo
Interview
The development of oncology drugs faces significant challenges, including a high failure rate (97%) in clinical trials, due to complex …
We at Receptor.AI are excited to present the next important milestone in the development of our next-generation AI docking model, …
Jan. 15, 2024
by Roman Kasianov
News
Mesenbio, a pioneering biotechnology firm emerging from the University of York, has recently secured a significant £1.4 million investment. This …
Jan. 12, 2024
by Dana Sokolova
Biopharma insight
In 2023, the venture capital (VC) landscape witnessed significant activity, providing crucial support to the biotech sector amidst a volatile …
Jan. 11, 2024
by Illia Petrov
News
Xcell Biosciences, Inc., a notable company in the field of cell and gene therapy applications, has recently unveiled a strategic …
Jan. 7, 2024
by Andrii Buvailo
News
Isomorphic Labs, a digital biology company specializing in AI applications, has entered into two distinct research collaborations with Eli Lilly …